Areteia Therapeutics
Clinical trials sponsored by Areteia Therapeutics, explained in plain language.
-
Asthma drug trial halted: hope for severe cases unfulfilled
Disease control TerminatedThis study tested an oral drug called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce asthma attacks and improve lung function over 52 weeks. However, t…
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 17, 2026 10:41 UTC
-
Asthma pill trial halted: hope for fewer attacks remains unproven
Disease control TerminatedThis study tested a daily pill called dexpramipexole for people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce serious asthma attacks over 52 weeks. The trial was terminated early,…
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 17, 2026 10:28 UTC
-
Asthma drug safety check: dexpramipexole under Long-Term review
Disease control TerminatedThis study looked at the long-term safety of dexpramipexole in adults with severe eosinophilic asthma. Participants were 509 people who had already completed an earlier phase III study. The main goal was to track side effects and changes in lab results, vital signs, and heart tes…
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:57 UTC